Copyright © 2000 by the European Society of Cardiology.
Editorial
Growth hormone and insulin-like growth factorfriends of the infarcted heart?
Department of Cardiology and Angiology, Medizinische Hochschule Hannover, Hannover, Germany
References
- Friberg L, Werner S, Eggertsen G, Ahnve S. Growth hormone and insulin-like growth factor-1 in acute myocardial infarction. Eur Heart J. 2000;21:15471554
[Abstract/Free Full Text] - Ren J, Samson WK, Sowers JR. Insulin-like growth factor I as a cardiac hormone. Physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol. 1999;31:20492061[CrossRef][ISI][Medline]
- de Gennaro Colonna V, Rossoni G, Bonacci D. Worsening of ischemic damage in hearts from rats with selective growth hormone deficiency. Eur J Pharmacol. 1996;314:333338[CrossRef][ISI][Medline]
- Locatelli V, Rossoni G, Schweiger F. Growth-hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology. 1999;140:40244031
[Abstract/Free Full Text] - Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA. 1995;92:80318035
[Abstract/Free Full Text] - Li B, Setoguchi M, Wang X. Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ Res. 1999;84:10071019
[Abstract/Free Full Text] - Reiss K, Meggs LG, Li P, Olivetti G, Capasso JM, Anversa P. Upregulation of IGF 1, IGF 1-receptor, and late growth related genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol. 1994;158:160168[CrossRef][ISI][Medline]
- Fazio S, Sabatini D, Capaldo B. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med. 1996;334:809814
[Abstract/Free Full Text] - Osterziel KJ, Strohm O, Schuler J. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet. 1998;351:12331237[CrossRef][ISI][Medline]
- Genth-Zotz S, Zotz R, Geil S, Voigtländer T, Meyer J, Darius H. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy. Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation. 1999;99:1821
[Abstract/Free Full Text] - Cittadini A, Grossman JD, Napoli R. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol. 1997;29:11091116[Abstract]
- Grimm D, Cameron D, Griese DP, Riegger GAJ, Kromer EP. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc Res. 1998;40:297306
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||